<DOC>
	<DOCNO>NCT01081652</DOCNO>
	<brief_summary>This open-label , randomize , comparative , phase III study evaluate safety efficacy Crinone 8 % comparison progesterone 60 mg intramuscular ( i.m . ) administer day luteal phase support 200 Chinese female subject undergo IVF/ET .</brief_summary>
	<brief_title>A Study Using Micronised Progesterone ( CrinoneÂ® 8 % ) Luteal Phase Support Women Undergoing Vitro Fertilisation ( IVF ) Embryo Transfer ( ET )</brief_title>
	<detailed_description>This open-label , randomize , comparative , multicentric , phase III study evaluate safety efficacy Crinone 8 % comparison progesterone 60 mg intramuscular administer day luteal phase support Chinese female subject undergo IVF/ET . The study plan enroll 200 female subject underwent pituitary down-regulation per center 's normal practice prior stimulation multiple follicular development . The progesterone administration start day ET . Randomisation perform day ET . If pregnancy confirm day 14 progesterone administration , progesterone continue another 45 day . The subject follow treatment outcome ( negative pregnancy test pregnancy ) record .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Patient give write informed consent BMI &lt; 25 kg/m2 Age &lt; 36 year &lt; 3 prior ART cycle ( IVF , ICSI relate procedure ) Infertility Regular spontaneous ovulatory menstrual cycle Habitual abortion Hydrosalpinges History past poor response COH Patients serious arterial , lung , hepatic renal disease Hepatic renal impairment</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Fertilisation , In vitro</keyword>
	<keyword>Embryo transfer</keyword>
	<keyword>progesterone</keyword>
	<keyword>Reproductive technology , Assisted</keyword>
</DOC>